MEDIBANK PRIVATE LIMITED (MPL)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

MPL - MEDIBANK PRIVATE LIMITED

FNArena Sector : Insurance
Year End: June
GICS Industry Group : Insurance
Debt/EBITDA: N/A
Index: ASX50 | ASX100 | ASX200 | ASX300 | ALL-ORDS

Medibank Private is the largest Australian private health insurance provider. Previously an Australian Government business enterprise, established by the Whitlam government in 1975, it was privatised in 2014.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$3.67

02 Jul
2024

-0.020

OPEN

$3.70

-0.54%

HIGH

$3.73

5,453,527

LOW

$3.67

TARGET
$3.827 4.3% upside
Franking for last dividend paid out: 100%
OTHER COMPANIES IN THE SAME SECTOR
AUB . CVW . FCL . GDG . HLI . IAG . NHF . NOL . PSI . QBE . SDF . SUN . TWR .
FNARENA'S MARKET CONSENSUS FORECASTS
MPL: 1
Title FY22
Actual		 FY23
Actual		 FY24
Forecast		 FY25
Forecast
EPS (cps) xxx 18.6 20.2 xxx
DPS (cps) xxx 14.6 16.1 xxx
EPS Growth xxx 29.8% 8.8% xxx
DPS Growth xxx 9.0% 10.1% xxx
PE Ratio xxx N/A 17.9 xxx
Dividend Yield xxx N/A 4.4% xxx
Div Pay Ratio(%) xxx 78.7% 79.6% xxx

Dividend yield today if purchased 3 years ago: 4.63%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

 4.03

Estimated Dividend Growth
(Average Of Past Three Years)

  %

Amount Invested

 $ 

Tell Me The Dividend After This Many Years
Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 29/02 - ex-div 7.2c (franking 100%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2024 FactSet UK Limited. All rights reserved
Title 201820192020202120222023
EPS Basic xxxxxxxxxxxxxxx18.6
DPS All xxxxxxxxxxxxxxx14.6
Sales/Revenue xxxxxxxxxxxxxxx7,460.1 M
Book Value Per Share xxxxxxxxxxxxxxx75.7
Net Operating Cash Flow xxxxxxxxxxxxxxx258.2 M
Net Profit Margin xxxxxxxxxxxxxxx6.85 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201820192020202120222023
Return on Capital Employed xxxxxxxxxxxxxxx25.36 %
Return on Invested Capital xxxxxxxxxxxxxxx24.93 %
Return on Assets xxxxxxxxxxxxxxx11.43 %
Return on Equity xxxxxxxxxxxxxxx25.36 %
Return on Total Capital xxxxxxxxxxxxxxx35.16 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx-124.1 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 201820192020202120222023
Short-Term Debt xxxxxxxxxxxxxxx31 M
Long Term Debt xxxxxxxxxxxxxxx24 M
Total Debt xxxxxxxxxxxxxxx55 M
Goodwill - Gross xxxxxxxxxxxxxxx283 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx421 M
Price To Book Value xxxxxxxxxxxxxxx4.65

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 201820192020202120222023
Capex xxxxxxxxxxxxxxx41.9 M
Capex % of Sales xxxxxxxxxxxxxxx0.56 %
Cost of Goods Sold xxxxxxxxxxxxxxx-
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx869 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx2,878 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.2

No. Of Recommendations

6
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Macquarie

xx/xx/xxxx

3

xxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Ord Minnett

xx/xx/xxxx

3

xxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgans

xx/xx/xxxx

3

xxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgan Stanley

26/02/2024

3

Equal-weight

$3.84

4.63%

Medibank Private's December-half result appears to have missed consensus' forecasts but outpaced Morgan Stanley's forecasts as structurally lower claims offsett weaker policyholder growth.

Management lowered FY24 residential policyholder growth guidance and the broker is now switching its focus to the publication of the December-quarter APRA Private Health Insurance Statistics on Wednesday.

Surgical claims recovered to pre-covid levels. EPS forecasts rise 2% in FY24; 5% in FY25; and 4% in FY26.

Equal-Weight rating retained. Target price rises to $3.84 from $3.66. Industry view is In-Line.

FORECAST
Morgan Stanley forecasts a full year FY24 dividend of 15.90 cents and EPS of 21.00 cents.
Morgan Stanley forecasts a full year FY25 dividend of 17.30 cents and EPS of 22.00 cents.

Citi

xx/xx/xxxx

3

xxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

UBS

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial
Access Stockbroker Research History >

MPL STOCK CHART

FNArena News on MPL

1
Rudi’s View: Copper, Lithium, Retailers & TechnologyOne

Jun 27 2024 - Rudi's View
2
Australian Broker Call *Extra* Edition – May 20, 2024

May 20 2024 - Daily Market Reports
3
ESG Focus: The Little Big Things – 15-05-2024

May 15 2024 - ESG Focus
4
Rudi’s View: More Positives Than Negatives

May 15 2024 - Rudi's View
5
Rudi’s View: Quality Reigns, And How To Identify It

May 01 2024 - Rudi's View

Latest Insurance News

1
Steadfast’s Long March

Jul 02 2024 - Australia
2
AUB Group Shares Poised For Break-Out

Jun 13 2024 - Technicals
3
SMSFundamentals: Older People Are Life Insurers’ Future Challenge

Oct 26 2023 - SMSFundamentals
4
Australian Insurers And The Weather

Oct 19 2023 - Feature Stories
5
Steadfast Group’s US Entry Full Of Promise

Oct 11 2023 - Australia
6
Pros And Cons Of Insurance Companies

Aug 02 2023 - Australia
7
Underlying Trends Positive For QBE Insurance

May 15 2023 - Australia
8
Rates Over Reinsurance For General Insurers 

Feb 01 2023 - Australia
9
Climate Costs Burden Heaviest For Aussie Insurers

Jun 01 2022 - Australia
10
In Brief: Risks From Russia, House Prices And Insurance Brokers

Feb 04 2022 - Australia